At a glance
ClinicalIndex Comparison RecordN/ACompleted· 12 enrolled
Drug / intervention
Caffeine 100mg / Albuterol 4mg +2 moredrug
Likely dose
Caffeine 100mg / Albuterol 4mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Effect on Body Composition With Albuterol and Caffeine Versus Placebo in Adolescents: A Pilot Study
In Brief
A clinical study evaluating Caffeine 100mg / Albuterol 4mg, Placebo, and 1 other intervention for Pediatric Obesity. Completed, enrolled 12 participants across 1 site.
Detailed Summary
The purpose of this study is to determine whether taking a combination of caffeine and albuterol three times per day will increase muscle and decrease fat in your child's body and to determine how these medications make your child feel. Albuterol is approved by the FDA for the treatment of asthma. It is not approved to increase muscle and decrease body fat in children.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPediatric Obesity
CountriesUnited States
Timeline
N/ACompletedFinished
20162017201820192020202120222023202420252026
Enrollment StartApr 2016
First PostedApr 2016
Primary CompletionOct 2017
Study CompletionOct 2017
TodayJul 2026
First PostedApr 15, 2016
Enrollment StartApr 1, 2016
Primary CompletionOct 24, 2017
Study CompletionOct 31, 2017
TodayJul 2, 2026
Enrollment to primary: 1.6 yearsPosted 10.2 years ago
Interventions
Caffeine 100mg / Albuterol 4mgdrug
Placebodrug
Family weight management counselingbehavioral